Centre's hypertension control initiative program expanded to 100 districts
New Delhi: To accelerate implementation of quality treatment for hypertension among Indians and prevent deaths from heart attack, stroke and kidney failure, the government announced on Wednesday the expansion of its India Hypertension Control Initiative (IHCI) to 100 districts covering all the states. According to government data, hypertension is the most common reason for sudden heart attack and is a leading cause of death in the country.... read more
UN working 'intensively' to stop Ebola in eastern DR Congo, following second case in major border town
Senior UN officials tasked with controlling the Ebola outbreak in the Democratic Republic of Congo (DRC) have responded to Tuesday's confirmation of a second case of Ebola in Goma, which resulted in the death of the patient. The senior officials stated that there is no evidence that the second case in Goma is linked to the first confirmed case.... read more
Chemo-free drug combo shows 'dramatic' improvement against common leukemia
When used together, two drugs that treat the most common leukemia in adults, significantly increase survival and lower the risk that the disease will worsen, according to a new study.
The interim analysis of a clinical trial for chronic lymphocytic leukemia, published in the New England Journal of Medicine, found that the drugs -- ibrutinib and rituximab -- fared better than a combination... read more
Laparoscopic Sacrocolpopexy Controls Pelvic Organ Prolapse Long-Term, Though Some Feel Worse
Four out of five patients who underwent laparoscopic sacrocolpopexy for symptomatic pelvic organ prolapse (POP) reported continued improvement of subjective symptoms an average of seven years later in a new study.
Of the remaining patients, most had recurrent prolapse, typically mid-vaginal, and a third reported urinary or bowel problems or painful intercourse, Dr. Jan Deprest of University Hospitals Leuven, in Belgium, and colleagues note in Obstetrics & Gynecology.... read more
Combination Generic Antiviral Tablet Effective for Hepatitis C
A fixed-dose combination tablet containing the generic direct-acting antiviral drugs sofosbuvir and daclatasvir provides high rates of sustained viral response in patients with hepatitis C, according to results from the SD1000 phase 3 clinical trial in Iran.... read more